Search Within

Heiko Schoder

  1. "Endocrinology"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (5)
  3. Editorial (1)
Groups
  1. Department of Medicine (16)
  2. Division of Subspecialty Medicine (16)
  3. Endocrinology (16)
  4. Molecular Imaging and Therapy Service (16)
  5. Radiology, Department of (16)
  6. Survivorship Research (13)

More Groups

People
  1. Robert Tuttle (10)
  2. Ronald Ghossein (9)
  3. Alan Ho (8)
  4. Steven Larson (8)
  5. Ravinder Grewal (6)
  6. Sofia Haque (6)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2013 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (4)
  2. European Journal of Nuclear Medicine and Molecular Imaging (3)
  3. Cancer (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Journal of Clinical Oncology (2)
  6. EJNMMI Research (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (4)
  2. Springer (4)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer
    Journal Article

    Grewal, R. K.; Tuttle, R. M.; Fox, J.; Borkar, S.; Chou, J. F.; Gonen, M.; Strauss, H. W.; Larson, S. M.; Schoder, H.
    Journal of Nuclear Medicine (2010)

    Fulltext@MSK | Save
  • Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma
    Journal Article

    Rivera, M.; Ghossein, R. A.; Schoder, H.; Gomez, D.; Larson, S. M.; Tuttle, R. M.
    Cancer (2008)

    Fulltext@MSK | Save
  • Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
    Journal Article

    Estilo, C. L.; Van Poznak, C. H.; Williams, T.; Bohle, G. C.; Lwin, P. T.; Zhou, Q.; Riedel, E. R.; Carlson, D. L.; Schoder, H.; Farooki, A.; more...
    The Oncologist (2008)

    Fulltext@MSK | Save
  • Would patient selection based on both calcitonin blood level and doubling time improve (18)F-FDG PET sensitivity in restaging of medullary thyroid cancer? - Reply
    Journal Article

    Schoder, H.; Tuttle, R. M.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save
  • Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels
    Journal Article

    Ong, S. C.; Schoder, H.; Patel, S. G.; Tabangay Lim, I. M.; Doddamane, I.; Gonen, M.; Shaha, A. R.; Tuttle, R. M.; Shah, J. P.; Larson, S. M.
    Journal of Nuclear Medicine (2007)

    Fulltext@MSK | Save